超越照护的运动与健康,MoviS:针对乳腺癌幸存者营养与运动教育项目的随机临床试验研究方案
MoviS是一项随机对照试验,计划纳入172例30-70岁、非转移性0-III期、术后6-12个月且完成放化疗、非体力活动的乳腺癌幸存者,随机分为接受生活方式建议联合MoviS训练的干预组与仅接受生活方式建议的对照组,主要结局为生活质量改善。
要点
- MoviS训练为12周有氧运动,每周2天监督下加1天非监督,强度为心率储备的40-70%,时长为20-60分钟。
- 两组均接受基于世界癌症研究基金会国际2018指南的营养与运动健康生活方式咨询。
- 主要结局为生活质量改善,次要结局包括地中海饮食依从性、体力活动水平、柔韧性、肌肉适能、疲劳、心肺适能等。
核心结论
- 该试验旨在评估监督下运动能否改善高复发风险乳腺癌幸存者的生活质量及健康相关因素。
研究设计与样本
- 随机对照试验,计划招募172例30-70岁、非转移性0-III期、非体力活动、术后6-12个月且完成化疗或放疗的乳腺癌幸存者,随机分配至干预组或对照组。
主要发现
- 干预组接受生活方式建议联合MoviS训练,训练为12周有氧运动,每周2天监督下加1天非监督,强度为心率储备的40-70%,时长为20-60分钟。
- 对照组仅接受生活方式建议,两组均接受基于世界癌症研究基金会国际2018指南的营养与运动健康生活方式咨询。
- 主要结局为生活质量改善;次要结局包括地中海饮食依从性、体力活动水平、柔韧性、肌肉适能、疲劳、心肺适能(估计最大摄氧量)、超声心动图参数、心率变异性(全部5分钟正常至正常间期标准差的平均值(ASDNN/5分钟)及24小时极低频和低频)以及代谢、内分泌和炎症血清生物标志物(血糖、胰岛素抵抗、孕酮、睾酮和高敏C反应蛋白)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验注册为回顾性注册,于2021年3月26日注册(ClinicalTrials.gov NCT04818359)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast cancer (BC) is the most common invasive cancer in women, and exercise can significantly improve the outcomes of BC survivors. MoviS (Movement and Health Beyond Care) is a randomized controlled trial aimed to evaluate the potential health benefits of exercise and proper nutritional habits. This study aims to assess the efficacy of aerobic exercise training in improving quality of life (QoL) and health-related factors in high-risk BC. METHODS: One hundred seventy-two BC survivor women, aged 30-70 years, non-metastatic, stage 0-III, non-physically active, 6-12 months post-surgery, and post chemo- or radiotherapy, will be recruited in this study. Women will be randomly allocated to the intervention arm (lifestyle recommendations and MoviS Training) or control arm (lifestyle recommendations). The MoviS training consists of 12 weeks of aerobic exercise training (2 days/week of supervised and 1 day/week of unsupervised exercise) with a progressive increase in exercise intensity (40-70% of heart rate reserve) and duration (20-60 min). Both arms will receive counseling on healthy lifestyle habits (nutrition and exercise) based on the World Cancer Research Fund International (WCRF) 2018 guidelines. The primary outcome is the improvement of the QoL. The secondary outcomes are improvement of health-related parameters such as Mediterranean diet adherence, physical activity level, flexibility, muscular fitness, fatigue, cardiorespiratory fitness (estimated maximal oxygen uptake), echocardiographic parameters, heart rate variability (average of the standard deviations of all 5 min normal to normal intervals (ASDNN/5 min) and 24 h very low and low frequency), and metabolic, endocrine, and inflammatory serum biomarkers (glycemia, insulin resistance, progesterone, testosterone, and high-sensitivity C-reactive protein). DISCUSSION: This trial aims to evaluate if supervised exercise may improve QoL and health-related factors of BC survivors with a high risk of recurrence. Findings from this project could provide knowledge improvement in the field of exercise oncology through the participation of a multidisciplinary team that will provide a coordinated program of cancer care to improve healthcare quality, improve prognosis, increase survival times and QoL, and reduce the risk of BC recurrence. TRIAL REGISTRATION: ClinicalTrials.gov NCT04818359 . Retrospectively registered on March 26, 2021.
引用
- Natalucci V, Ferri Marini C, De Santi M, et al. Movement and health beyond care, MoviS: study protocol for a randomized clinical trial on nutrition and exercise educational programs for breast cancer survivors. Trials. 2023. PMID: 36814313. doi:10.1186/s13063-023-07153-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。